The K 3.1 channel (KCNN4) is an important modulator of microglia responses in rodents, but no information exists on functional expression on microglia from human adults. We isolated and cultured microglia (max 1% astrocytes, no neurons or oligodendrocytes) from neocortex surgically removed from epilepsy patients and employed electrophysiological whole-cell measurements and selective pharmacological tools to elucidate functional expression of K 3.1. The channel expression was demonstrated as a significant increase in the voltage-independent current by NS309, a K 3.1/K 2 activator, followed by full inhibition upon co-application with NS6180, a highly selective K 3.1 inhibitor. A major fraction (79%) of unstimulated human microglia expressed K 3.1, and the difference in current between full activation and inhibition (ΔK 3.1) was estimated at 292 ± 48 pA at -40 mV (n = 75), which equals at least 585 channels per cell. Serial K 3.1 activation/inhibition significantly hyperpolarized/depolarized the membrane potential. The isolated human microglia were potently activated by lipopolysaccharide (LPS) shown as a prominent increase in TNF-α production. However, incubation with LPS neither changed the K 3.1 current nor the fraction of K 3.1 expressing cells. In contrast, the anti-inflammatory cytokine IL-4 slightly increased the K 3.1 current per cell, but as the membrane area also increased, there was no significant change in channel density. A large fraction of the microglia also expressed a voltage-dependent current sensitive to the K 1.1 modulators NS1619 and Paxilline and an inward-rectifying current with the characteristics of a K channel. The high functional expression of K 3.1 in microglia from epilepsy patients accentuates the need for further investigations of its role in neuropathological processes. GLIA 2016;64:2065-2078.